Laue Katelyn, Schultz Megan, Talbot-Montgomery Elizabeth, Garrick Alexandra, Java Anuja, Corbett Christine, Lammert Dana M, Rogers JoAnna, Davis Kathleen, Malhotra Kunal, Philipneri Marie, Kimbel Mary Ann, Mustafa Reem A, Hardesty Valerie
National Kidney Foundation, New York, NY.
Division of Nephrology, Washington University School of Medicine, St. Louis, MO.
Mayo Clin Proc Innov Qual Outcomes. 2024 Jan 12;8(1):82-96. doi: 10.1016/j.mayocpiqo.2023.12.004. eCollection 2024 Feb.
Ninety percent of people with chronic kidney disease (CKD) remain undiagnosed, most people at risk do not receive guideline-concordant testing, and disparities of care and outcomes exist across all stages of the disease. To improve CKD diagnosis and management across primary care, the National Kidney Foundation launched a collective impact (CI) initiative known as Show Me CKDintercept. The initiative was implemented in Missouri, USA from January 2021 to June 2022, using a data strategy, stakeholder engagement and relationship mapping, learning in action working groups (LAWG), and a virtual leadership summit. The Reach, Effectiveness, Adoption, Implementation, and Maintenance framework was used to evaluate success. The initiative united 159 stakeholders from 81 organizations (Reach) to create an urgency for change and engage new CKD champions (Effectiveness). The adoption resulted in 53% of participants committed to advancing the roadmap (Adoption). Short-term results reported success in laying a foundation for CI across Missouri. The long-term success of the CI initiative in addressing the public health burden of kidney disease remains to be determined. The project reported the potential use of a CI initiative to build leadership consensus to drive measurable public health improvements nationwide.
90%的慢性肾脏病（CKD）患者仍未被诊断出来，大多数有患病风险的人未接受符合指南的检测，并且在疾病的各个阶段都存在护理和治疗结果的差异。为了改善初级保健中慢性肾脏病的诊断和管理，美国国家肾脏基金会发起了一项名为“向我展示慢性肾脏病拦截行动”（Show Me CKDintercept）的集体影响（CI）倡议。该倡议于2021年1月至2022年6月在美国密苏里州实施，采用了数据策略、利益相关者参与和关系映射、行动中学习工作组（LAWG）以及虚拟领导力峰会等方式。采用了“覆盖范围、有效性、采用率、实施情况和维持情况”框架来评估成效。该倡议联合了来自81个组织的159名利益相关者（覆盖范围），以营造变革的紧迫感并吸引新的慢性肾脏病倡导者（有效性）。采用率方面，53%的参与者致力于推进路线图（采用率）。短期结果表明，该倡议成功为密苏里州的集体影响奠定了基础。该集体影响倡议在解决肾脏疾病公共卫生负担方面的长期成功仍有待确定。该项目报告了集体影响倡议在建立领导共识以推动全国范围内可衡量的公共卫生改善方面的潜在用途。
